Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.98B 3.65B 3.4B 6.45B 433B 6.56B 43.96B 17.04B 212B 17.08B 16.71B 732B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.11B 3.77B 3.52B 6.67B 447B 6.78B 45.39B 17.59B 219B 17.64B 17.26B 756B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 3 months | +0.35% | ||
| 6 months | +1.54% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 5.88 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-26 | Issuer sale | Director | 395,940 | 0.1261% | ||
| 04-26 | Issuer sale | Director | 392,483 | 0.1250% | ||
| 04-26 | Issuer sale | Director | 310,136 | 0.0988% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +143.53% | +15.37% | 4.55B | |
| +0.36% | +5.10% | +1.04% | +5.85% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.99% | +1.26% | +13.98% | +18.88% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | +1.19% | +5.81% | +78.95% | +93.37% | 24.68B | |
| Weighted average by Cap. | +1.27% | +6.61% | +89.35% | +128.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 462M 424M 395M 749M 50.29B 762M 5.1B 1.98B 24.67B 1.98B 1.94B 85B | 634M 554M 509M 475M 900M 60.38B 915M 6.13B 2.37B 29.61B 2.38B 2.33B 102B |
| Net income | -56.11M -49.03M -45.02M -41.98M -79.59M -5.34B -80.93M -542M -210M -2.62B -211M -206M -9.03B | -27.11M -23.69M -21.75M -20.29M -38.46M -2.58B -39.11M -262M -102M -1.27B -102M -99.58M -4.36B |
| Net Debt | 194M 169M 155M 145M 275M 18.44B 279M 1.87B 725M 9.04B 727M 711M 31.17B | 149M 130M 119M 111M 211M 14.17B 215M 1.44B 557M 6.95B 559M 547M 23.95B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
